Re-reading my post, I concede that it could have been taken that way and I should have worded my first statement differently.
My point though, was that the fact that it's "novel", from an approval perspective, doesn't in any way translate to it necessarily being a more safe/effective treatment or "game-changing".
BOT - Anything but charting, page-10419
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.005(1.56%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 32.5¢ | $83.51K | 256.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 744899 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 181256 | 4 |
View Market Depth
| Last trade - 10.05am 15/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |